AGP (KAR:AGP) Beneish M-Score: -2.54 (As of Jun. 26, 2026)


KAR:AGP AGP Ltd KAR:AGP
96 GF Score
Price ₨204.97
GF Value ₨186.61
Valuation Fairly Valued
! 1 Warning Sign
View Full Analysis

What is AGP Beneish M-Score?

AGP KAR:AGP +0.40% 96 Beneish M-Score is -2.54 as of Jun. 26, 2026. GuruFocus rates KAR:AGP with a GF Score™ of 96/100 and a GF Value™ of ₨186.61 (Fairly Valued). The stock has 1 warning sign investors should review. Among 911 Drug Manufacturers companies, AGP ranks better than 53.68% on this metric.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.54 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for AGP's Beneish M-Score or its related term are showing as below:

KAR:AGP' s Beneish M-Score Range Over the Past 10 Years
Min: -3.81   Med: -2.41   Max: -1.16
Current: -2.54

During the past 10 years, the highest Beneish M-Score of AGP was -1.16. The lowest was -3.81. And the median was -2.41.


AGP Beneish M-Score Historical Data

* Premium members only.

The historical data trend for AGP's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

AGP Beneish M-Score Chart

AGP Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.39 -2.00 -2.51 -2.85 -2.61

AGP Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.82 -3.01 -2.82 -2.61 -2.54

KAR:AGP vs ZTS, UTHR, VTRS: Beneish M-Score Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, AGP's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


AGP Beneish M-Score vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, AGP's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where AGP's Beneish M-Score falls into.


KAR:AGP
96GF Score
AGP Ltd KAR:AGP
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

AGP Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of AGP for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.0457+0.528 * 0.9905+0.404 * 0.9436+0.892 * 1.0878+0.115 * 0.913
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 1.2066+4.679 * -0.030206-0.327 * 0.8972
=-2.54

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar26) TTM:Last Year (Mar25) TTM:
Total Receivables was ₨3,235 Mil.
Revenue was 6850.132 + 8548.129 + 7624.268 + 5557.771 = ₨28,580 Mil.
Gross Profit was 3992.696 + 5164.104 + 4725.938 + 3256.001 = ₨17,139 Mil.
Total Current Assets was ₨9,327 Mil.
Total Assets was ₨32,582 Mil.
Property, Plant and Equipment(Net PPE) was ₨5,656 Mil.
Depreciation, Depletion and Amortization(DDA) was ₨544 Mil.
Selling, General, & Admin. Expense(SGA) was ₨4,522 Mil.
Total Current Liabilities was ₨8,765 Mil.
Long-Term Debt & Capital Lease Obligation was ₨5,345 Mil.
Net Income was 857.236 + 1238.546 + 1041.808 + 617.028 = ₨3,755 Mil.
Non Operating Income was 0 + 0 + 0 + 0 = ₨0 Mil.
Cash Flow from Operations was 87.722 + 2060.834 + 1347.255 + 1242.965 = ₨4,739 Mil.
Total Receivables was ₨2,844 Mil.
Revenue was 7159.597 + 7383.968 + 6007.611 + 5721.674 = ₨26,273 Mil.
Gross Profit was 4123.456 + 4736.63 + 3615.117 + 3130.81 = ₨15,606 Mil.
Total Current Assets was ₨8,603 Mil.
Total Assets was ₨30,719 Mil.
Property, Plant and Equipment(Net PPE) was ₨4,531 Mil.
Depreciation, Depletion and Amortization(DDA) was ₨395 Mil.
Selling, General, & Admin. Expense(SGA) was ₨3,445 Mil.
Total Current Liabilities was ₨7,647 Mil.
Long-Term Debt & Capital Lease Obligation was ₨7,181 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(3235.46 / 28580.3) / (2844.215 / 26272.85)
=0.113206 / 0.108257
=1.0457

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(15606.013 / 26272.85) / (17138.739 / 28580.3)
=0.593998 / 0.59967
=0.9905

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (9327.422 + 5656.095) / 32581.738) / (1 - (8603.337 + 4531.243) / 30719.3)
=0.540125 / 0.572432
=0.9436

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=28580.3 / 26272.85
=1.0878

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(394.583 / (394.583 + 4531.243)) / (543.977 / (543.977 + 5656.095))
=0.080105 / 0.087737
=0.913

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(4522.398 / 28580.3) / (3445.446 / 26272.85)
=0.158235 / 0.131141
=1.2066

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((5345.384 + 8765.062) / 32581.738) / ((7180.859 + 7646.62) / 30719.3)
=0.433078 / 0.482676
=0.8972

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(3754.618 - 0 - 4738.776) / 32581.738
=-0.030206

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

AGP has a M-score of -2.54 suggests that the company is unlikely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →
What does a Beneish M-Score of -2.54 mean?
AGP (KAR:AGP) has a Beneish M-Score of -2.54 as of Jun. 26, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on AGP and its competitors. According to the industry distribution chart, AGP ranks #422 out of 911 companies in the Drug Manufacturers industry, placing it in the top 46.3%.
Is AGP's Beneish M-Score too high?
AGP's current Beneish M-Score is -2.54. Based on the distribution chart, AGP ranks #422 out of 911 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, AGP has a GF Score™ of 96/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does AGP's Beneish M-Score compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, AGP ranks #422 out of 911 companies for Beneish M-Score. This puts AGP in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Drug Manufacturers company?
A good Beneish M-Score depends on the Drug Manufacturers industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on AGP and its competitors. AGP's current Beneish M-Score is -2.54. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AGP stock overvalued right now?
Based on GuruFocus' analysis, AGP (KAR:AGP) is currently considered Fairly Valued. The stock's GF Value™ is ₨186.61, compared to a current price of ₨204.97 — trading 9.8% above its estimated fair value. The current Beneish M-Score is -2.54. AGP's overall GF Score™ is 96/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For AGP (KAR:AGP), the current Beneish M-Score is -2.54 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is AGP (KAR:AGP) Overvalued in 2026?

Based on GuruFocus' analysis, AGP stock appears to be overvalued. The current stock price of ₨204.97 is trading 9.8% above its estimated GF Value™ of ₨186.61. GuruFocus considers AGP to be Fairly Valued.

Key valuation signals for KAR:AGP:

  • Beneish M-Score: -2.54
  • GF Value™: ₨186.61 vs. price of ₨204.97 (9.8% above fair value)
  • GF Score™: 96/100 with 1 warning sign

No single metric tells the full story. See the KAR:AGP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


AGP Business Description

Address B-23C, S.I.T.E, Karachi, PAK, 75700
AGP Ltd is a pharmaceutical company engaged in the manufacturing and marketing of products under licensing arrangements with other pharmaceutical companies. The company has two manufacturing facilities situated in the S.I.T.E industrial area, Karachi, Pakistan. Its key products include Nergab, Afdol, Nebcin, and others.
96GF Score

Get the complete analysis for KAR:AGP

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₨204.97
Price
₨186.61
GF Value